• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY CMW - 9610921 DEPUY1 GENTAMICIN CEMENT 40G; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY CMW - 9610921 DEPUY1 GENTAMICIN CEMENT 40G; BONE CEMENT : BONE CEMENT Back to Search Results
Model Number 5450-31-500
Device Problem Loss of or Failure to Bond (1068)
Patient Problems Muscular Rigidity (1968); Necrosis (1971); Pain (1994); Ambulation Difficulties (2544); Joint Laxity (4526); Swelling/ Edema (4577); Insufficient Information (4580)
Event Date 10/17/2022
Event Type  Injury  
Event Description
Clinical adverse event received for failed patellar component.Patellar migration/loosening.Event is serious and is considered severe.Event is possibly related to both device and procedure.Date of implant: (b)(6) 2020; date of event: (b)(6) 2022; (left knee).Treatment: revision; patella and insert were revised.
 
Manufacturer Narrative
Product complaint # (b)(4).Dmf# - 13704; trade name gentamicin sulphate; active ingredient(s) gentamicin sulphate; dosage form - powder; strength 1.0g active in our cements.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : the device associated with this report was not returned for analysis.Review of the photographic evidence was not able to confirm the complaint, in order to confirm loosening a series of chronological x-rays is needed.No other defects were identified.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device history lot : the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Event Description
Medical records received.Patient reports pain, stiffness, and walking difficulty in left knee 2 years s/p left knee revision of tibial tray and patella due to loosening.Physical exam identifies sizable effusion as well as 1-2 mm laxity with extension.Imaging indicates a failure of the patella.The patient will return for a detailed exam with the surgeon.Clinic note dated (b)(6) 2022: the surgeon determines the natural paella has fractured due to avascular necrosis.There is no indication of failure of the patellar button.The surgeon performs a joint aspiration of 70 ml from the left knee.The patient will continue to be monitored.No further intervention was provided.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: added: b5, h6 health effect - clinical code.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DEPUY1 GENTAMICIN CEMENT 40G
Type of Device
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY CMW - 9610921
cornford rd
cornford rd
blackpool FY4 4 QQ
UK  FY4 4QQ
Manufacturer (Section G)
DEPUY CMW - 9610921
cornford rd
blackpool FY4 4 QQ
UK   FY4 4QQ
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key15742794
MDR Text Key303142445
Report Number1818910-2022-22178
Device Sequence Number1
Product Code MBB
UDI-Device Identifier10603295174264
UDI-Public10603295174264
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K081163
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 11/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number5450-31-500
Device Catalogue Number545031500
Device Lot Number9322352
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/18/2022
Initial Date FDA Received11/07/2022
Supplement Dates Manufacturer Received11/03/2022
12/09/2022
Supplement Dates FDA Received11/23/2022
12/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/03/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ATTUNE MEDIAL DOME PAT 38MM; ATTUNE PS RP INSRT SZ 5 10MM; ATTUNE RP TIB BASE SZ 4 CEM; DEPUY1 GENTAMICIN CEMENT 40G; DEPUY1 GENTAMICIN CEMENT 40G
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient SexFemale
Patient Weight68 KG
Patient RaceWhite
-
-